Best Practice Guidelines

The EMQN community is committed to educating genomic diagnostic service providers in providing the best possible service. We do this through regularly publishing best practice guidelines on the optimum way to test for and report on a wide range of specific diseases. We have adopted an internationally robust method of crafting our guidelines to ensure they are credible and comprehensive.

Our guidelines below are freely available to view and download below.

  • Category

In 2008 the European Molecular Genetics Quality Network (EMQN) for the first time offered a European-wide external quality assessment scheme for CAH (due to 21-OH deficiency).
Dystrophinopathies are X-linked diseases, including Duchenne muscular dystrophy and Becker muscular dystrophy, due to DMD gene variants.
Monogenic autoinflammatory diseases are caused by pathogenic variants in genes that regulate innate immune responses, and are characterized by sterile systemic inflammatory episodes.
Initial guidelines for the laboratory analysis of PWS and AS were prepared by John Harvey for the CMGS in August 1998.
A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Guidelines resulting from 3 workshops organised and funded by Eurogentest. EMQN contributed to these workshops.
  • Category

In 2008 the European Molecular Genetics Quality Network (EMQN) for the first time offered a European-wide external quality assessment scheme for CAH (due to 21-OH deficiency).
Dystrophinopathies are X-linked diseases, including Duchenne muscular dystrophy and Becker muscular dystrophy, due to DMD gene variants.
Monogenic autoinflammatory diseases are caused by pathogenic variants in genes that regulate innate immune responses, and are characterized by sterile systemic inflammatory episodes.
Initial guidelines for the laboratory analysis of PWS and AS were prepared by John Harvey for the CMGS in August 1998.
A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Guidelines resulting from 3 workshops organised and funded by Eurogentest. EMQN contributed to these workshops.

Thought leadership

We also offer a range of other materials to assist you in improving your testing and reporting capabilities.

Calendar

Click on links below to download the calendars for 2022 and 2023 (last updated 16/09/2022)

Monitoring procedures

Molecular pathology schemes

Disease-specific and technical schemes